TTM
$7.80B
YoY change
+88.5%
5Y CAGR
+1.2%
Peak year (2018)
$8.39B
Cumulative net income
$124.89B
Net Income history chart for Amgen (AMGN) from 1985 to 2025
Latest: $7.71B
Net Income growth chart for Amgen (AMGN) from 1985 to 2025
Latest: +88.5%
Net Income history table for Amgen (AMGN) from 1985 to 2025
| 2025 | $7.71B | +88.5% | +$3.62B | ||
| 2024 | $4.09B | -39.1% | −$2.63B | ||
| 2023 | $6.72B | +2.5% | +$165.00M | ||
| 2022 | $6.55B | +11.2% | +$659.00M | ||
| 2021 | $5.89B | -18.9% | −$1.37B | ||
| 2020 | $7.26B | -7.4% | −$578.00M | ||
| 2019 | $7.84B | -6.6% | −$552.00M | ||
| 2018 | $8.39B | +324.2% | +$6.42B | ||
| 2017 | $1.98B | -74.4% | −$5.74B | ||
| 2016 | $7.72B | +11.3% | +$783.00M | ||
| 2015 | $6.94B | +34.5% | +$1.78B | ||
| 2014 | $5.16B | +1.5% | +$77.00M | ||
| 2013 | $5.08B | +16.9% | +$736.00M | ||
| 2012 | $4.34B | +18.0% | +$662.00M | ||
| 2011 | $3.68B | -20.4% | −$944.00M | ||
| 2010 | $4.63B | +0.5% | +$22.00M | ||
| 2009 | $4.61B | +9.7% | +$409.00M | ||
| 2008 | $4.20B | +32.5% | +$1.03B | ||
| 2007 | $3.17B | +7.3% | +$216.00M | ||
| 2006 | $2.95B | -19.7% | −$724.00M | ||
| 2005 | $3.67B | +55.5% | +$1.31B | ||
| 2004 | $2.36B | +4.6% | +$103.50M | ||
| 2003 | $2.26B | -262.3% | +$3.65B | ||
| 2002 | −$1.39B | -224.3% | −$2.51B | ||
| 2001 | $1.12B | -1.7% | −$18.80M | ||
| 2000 | $1.14B | +3.8% | +$42.10M | ||
| 1999 | $1.10B | +27.0% | +$233.20M | ||
| 1998 | $863.20M | +34.0% | +$218.90M | ||
| 1997 | $644.30M | -5.2% | −$35.50M | ||
| 1996 | $679.80M | +26.4% | +$142.10M | ||
| 1995 | $537.70M | +68.2% | +$218.00M | ||
| 1994 | $319.70M | -16.6% | −$63.60M | ||
| 1993 | $383.30M | +7.2% | +$25.70M | ||
| 1992 | $357.60M | +265.3% | +$259.70M | ||
| 1991 | $97.90M | +412.6% | +$78.80M | ||
| 1990 | $19.10M | — | — | ||
| 1988 | −$8.20M | -582.4% | −$9.90M | ||
| 1987 | $1.70M | +112.5% | +$900.00K | ||
| 1986 | $800.00K | +60.0% | +$300.00K | ||
| 1985 | $500.00K | — | — |
- 2025$7.71B+88.5%
- 2024$4.09B-39.1%
- 2023$6.72B+2.5%
- 2022$6.55B+11.2%
- 2021$5.89B-18.9%
- 2020$7.26B-7.4%
- 2019$7.84B-6.6%
- 2018$8.39B+324.2%
- 2017$1.98B-74.4%
- 2016$7.72B+11.3%
- 2015$6.94B+34.5%
- 2014$5.16B+1.5%
- 2013$5.08B+16.9%
- 2012$4.34B+18.0%
- 2011$3.68B-20.4%
- 2010$4.63B+0.5%
- 2009$4.61B+9.7%
- 2008$4.20B+32.5%
- 2007$3.17B+7.3%
- 2006$2.95B-19.7%
- 2005$3.67B+55.5%
- 2004$2.36B+4.6%
- 2003$2.26B-262.3%
- 2002−$1.39B-224.3%
- 2001$1.12B-1.7%
- 2000$1.14B+3.8%
- 1999$1.10B+27.0%
- 1998$863.20M+34.0%
- 1997$644.30M-5.2%
- 1996$679.80M+26.4%
- 1995$537.70M+68.2%
- 1994$319.70M-16.6%
- 1993$383.30M+7.2%
- 1992$357.60M+265.3%
- 1991$97.90M+412.6%
- 1990$19.10M—
- 1988−$8.20M-582.4%
- 1987$1.70M+112.5%
- 1986$800.00K+60.0%
- 1985$500.00K—
Net Income values are taken from Amgen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's current net income (TTM) is $7.80B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Amgen (AMGN) net income is $7.71B – surged 88.5% year-over-year.
Over 2020–2025 (5 years), Amgen net income expanded at a +1.2% compound annual rate, with mixed annual results across the window.
Between 2018 and 2025, Amgen net income declined 8.1%, falling from $8.39B to $7.71B.
$8.39B stands as the all-time-high annual net income, posted in 2018, against a low of −$1.39B during 2002.
Amgen Net Income by Year
Amgen Net Income 2025: $7.71B
Amgen posted net income of $7.71B in 2025, surged 88.5% from 2024.
Amgen Net Income 2024: $4.09B
In 2024, Amgen reported net income of $4.09B, plunged 39.1% below 2023.
Amgen Net Income 2023: $6.72B
Amgen net income in 2023 was $6.72B, edged up 2.5% from 2022.
Amgen Net Income 2022: $6.55B
2022's net income for Amgen came in at $6.55B, grew 11.2% from 2021.
Amgen Net Income 2021: $5.89B
Amgen net income in 2021 was $5.89B.
See more financial history for Amgen (AMGN).
Sector peers by Net Income
Healthcare peers of Amgen (AMGN), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $6.74B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $4.23B
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation